Notícias

ARM stock rose 17% on Tuesday, piquing interest among retail traders.

Every dollar hyperscalers spend building alternatives to Nvidia has to go somewhere, and one company keeps collecting it across custom silicon, switch fabric, and AI networking without most investors noticing.

Now is the time to buy hyperscaler stocks as they start to break out.

Investors backed AI-driven growth across infrastructure, cybersecurity, and cloud software sectors.

(Bloomberg) -- Shares of SK Hynix Inc. advanced, lifted by an overnight rally in US chipmakers and speculation that the Korean firm may soon unveil buybacks and other details of a broader shareholder return plan. Most Read from BloombergBeer Dynasty Families Sell €731 Million Stake in AB InBevTaco Bell Met With Michigan on Parasite Weeks Before RecallChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersIran Weighs Allowing Europe to Clear Mines in Strait of HormuzTrump Discusses Iran W

GM has taken on considerable cost in recent years to reorganize its China business and facilitate new vehicle launches in the country.

The data management specialist is partnering with an artificial intelligence (AI) leader.

RWR delivered higher returns over the last year with lower fees, while GQRE offers broader international exposure and a higher dividend yield.

Amazon's cloud dominance and fortress balance sheet clash with Carnival's cyclical recovery and cheaper valuation; each offers a distinct risk-reward profile.

In its most recent quarter, Microsoft Cloud's revenue was $59.3 billion, up 27% year over year,

Rocket Lab will develop advanced “Flatellites” equipped with space-based sensors and low-latency, high-bandwidth communications.

Wayfair Inc. (NYSE:W) soared by 29.73 percent on Tuesday to close at $116.08 apiece, after delivering its strongest sales growth since the pandemic in the second quarter of the year, signaling growing momentum in the company’s recovery. In an updated report, the home furnitures retailer said that net revenues during the period increased by 7.5 […]

Amazon's net margin climbed to 10.8% while Dutch Bros trades at a 71.6x forward P/E, a stark contrast in profitability and valuation.

Charles Schwab recently declared a regular quarterly cash dividend of US$0.32 per common share, alongside several preferred stock dividends payable in August and September 2026 to shareholders of record in mid-August. The company also released its Q3 2026 Retail Client Sentiment Report showing a sharp rise in bullish views and a strong willingness among active traders to buy market dips, underlining Schwab’s central role in shaping retail investor behavior. With Schwab’s latest sentiment...

The latest analyst work on Coca-Cola has lifted fair value estimates from US$88.22 to US$94.70, signaling a modest reset in where some see the stock’s longer term potential. Much of this move tracks directly to recent research following Coca-Cola’s Q2 2026 results and updated guidance, where many firms raised price targets but differed on how much upside remains. As you read on, you will see how this evolving narrative could shape the way you follow Coca-Cola from here. Analyst Price Targets...

SpaceX announced its first earnings since its June IPO, cutting its losses and growing its revenue more than expected.

Is Chipotle facing another food safety crisis?

Apple is entering a new era, but it should remain a market-beater over the long run.

Par Petroleum (PARR) delivered earnings and revenue surprises of +23.17% and +19.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Intrepid Potash (IPI) delivered earnings and revenue surprises of +47.37% and +0.52%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cricut (CRCT) delivered earnings and revenue surprises of +375.00% and -6.89%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Amprius (AMPX) delivered earnings and revenue surprises of 0.00% and +17.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Astera Labs, Inc. (ALAB) delivered earnings and revenue surprises of +15.94% and +8.93%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

The company reported a notable insider sale that reduced their indirect holdings by 21% as the stock surged 470% over the past year.

President Donald Trump discussed efforts to de-escalate US-Iran tensions with Qatari Emir Tamim bin Hamad Al Thani.

SpaceX's revenue jumped 92 percent in the second quarter, beating analyst expectations by around $1 billion in its first post-IPO earnings report, but shares tumbled as investors remained skeptical about the company's ability to deliver on lofty promises. Investors remain skeptical even with SpaceX beating expectations, Emarketer Senior Analyst Gadjo Sevilla told AFP.  "I don't think people want to hear promises about the next five years or a mission to Mars," Sevilla said. 

A SpaceX Falcon 9 rocket launches on July 30 at Cape Canaveral in Florida. NurPhoto/Getty Images SpaceX shares, which fell in recent weeks after popping about 20% in its June 12 IPO, dropped about 6% Tuesday after reporting its first quarterly earnings. For its venture capital investors, the slump presents a liquidity hiccup: SpaceX, in its IPO filings, imposed a tiered lockup on private-market investors selling shares. The first earnings release opens an initial window to sell up to 20% of rest

Intel (INTC) heads into the Future of Memory and Storage 2026 conference in Santa Clara with investors weighing fresh Q2 results, updated revenue guidance, and new AI focused partnerships across PCs, packaging, and foundry services. See our latest analysis for Intel. Intel’s recent conference buzz, new AI PC and packaging collaborations, and stronger Q2 guidance sit against a mixed price pattern. The share price is up 10.92% over one day and 16.96% over seven days, yet down 16.13% over 30...

Allergan Aesthetics, an AbbVie company, reported that the FDA has accepted for review a supplemental Biologics License Application for BOTOX Cosmetic to treat masseter muscle prominence. If cleared, BOTOX Cosmetic would be the first neurotoxin approved in the U.S. for this condition, supported by positive Phase 3 trial data. The filing highlights AbbVie’s push to broaden its aesthetics offerings beyond current BOTOX Cosmetic indications. AbbVie (NYSE:ABBV) is drawing fresh attention to its...